Compare CGTX & GLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CGTX | GLU |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.4M | 116.8M |
| IPO Year | 2021 | N/A |
| Metric | CGTX | GLU |
|---|---|---|
| Price | $1.42 | $19.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | ★ 969.0K | 12.4K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.60% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $11.61 |
| 52 Week High | $3.83 | $15.40 |
| Indicator | CGTX | GLU |
|---|---|---|
| Relative Strength Index (RSI) | 44.59 | 62.04 |
| Support Level | $1.34 | $19.07 |
| Resistance Level | $1.57 | $19.60 |
| Average True Range (ATR) | 0.11 | 0.36 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 27.59 | 64.13 |
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.